Regulatory Landscape
Indonesia's Healthcare Market
Indonesia is Southeast Asia's largest economy and most populous country (270+ million people), with a rapidly modernising healthcare infrastructure. The government's universal health coverage programme (Jaminan Kesehatan Nasional, JKN), introduced in 2014, has dramatically expanded access to medical care and driven significant growth in demand for medical devices.
This growth has made Indonesia one of the most strategically important markets in the ASEAN region — but also one of the most complex to navigate for foreign manufacturers.
The Dual-Authority Structure
One of the most important features of Indonesia's regulatory landscape is its dual-authority structure:
| Authority | Indonesian Name | Scope |
|---|---|---|
| Ministry of Health | Kementerian Kesehatan (Kemenkes) | Medical device registration (NIE), Regalkes portal, distribution licences (IDAK), market surveillance |
| National Agency of Drug and Food Control | Badan Pengawas Obat dan Makanan (BPOM / NADFC) | Pharmaceuticals, traditional medicines, cosmetics, food, health supplements, GMP inspections of device manufacturers |
Your primary regulator is Kemenkes, not BPOM. The NIE (Nomor Izin Edar) that authorises your device for sale is issued by Kemenkes via the Regalkes portal. BPOM may be involved in GMP inspections and clinical trial authorisations, but it does not issue device marketing approvals.
Key Regulatory Milestones
| Year | Development |
|---|---|
| 2017 | Permenkes No. 62/2017 consolidates medical device registration rules — the primary regulation still in force |
| 2014 | JKN universal health coverage launched, driving device market growth |
| 2021 | CDAKB (Good Distribution Practice) requirements strengthened; Online Single Submission (OSS) system introduced |
| 2024 | CDAKB certification made mandatory before new NIE applications (July 2024); Government Regulation 42/2024 introduces phased Halal labeling obligations |
| 2025 | Permenkes No. 11/2025 formalises e-labeling provisions for professional-use devices |
Indonesia and ASEAN Harmonisation
Indonesia is a founding member of ASEAN and a signatory to the ASEAN Medical Device Directive (AMDD). This means:
- Indonesia's device classification rules align with the GHTF/ASEAN four-class system (A–D)
- Submissions use the ASEAN Common Submission Dossier Template (CSDT)
- Indonesia participates in ASEAN mutual recognition discussions
However, ASEAN harmonisation is not equivalent to automatic recognition. Approval in Singapore (HSA), Malaysia (MDA), or Thailand does not eliminate the need for Indonesian registration. Each device still requires its own NIE from Kemenkes.
How Indonesia Compares Internationally
| Feature | Indonesia | Singapore (HSA) | Malaysia (MDA) | Australia (TGA) |
|---|---|---|---|---|
| Class system | A–D | A–D | A–D | I–III + AIMD |
| Dossier format | ASEAN CSDT | ASEAN CSDT | ASEAN CSDT | ARTG dossier |
| Foreign approval recognised? | Supporting only | Supporting only | Supporting only | Supporting only |
| Local representative required? | Yes (mandatory) | Yes (LAR) | Yes (mandatory) | Sponsor required |
| Registration validity | 5 years | 5 years | 5 years | Indefinite (ARTG) |
| Online portal | Regalkes | PRISM | MyMDA | TBS |
Strategic Considerations for Market Entry
1. Early appointment of a Local Authorised Representative (LAR) The LAR must hold both an IDAK and CDAKB certificate before any registration can proceed. Establishing this relationship early is the single most important step.
2. Document preparation takes longer than expected Embassy legalisation and apostille of the Letter of Authorization, Free Sale Certificate, and GMP certificates can add 3–6 months to the timeline. Plan accordingly.
3. One NIE, one holder Under Permenkes No. 62/2017, each device (under one trade name) may only be registered by one Indonesian entity at a time. Choosing between your distributor and a neutral licence holder has significant long-term strategic implications.
4. Halal labeling is now on the horizon Government Regulation 42/2024 introduces phased mandatory Halal compliance. Class A devices must comply by October 2026. Manufacturers with animal-derived materials should begin preparation now.